An observational study in Cardiac Diseases, sponsored by Rambam Health Care Campus. Completed at 1 site in Israel. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2011-08-18.
Sponsored by Rambam Health Care Campus · Observational
Myocardial scintigraphy with 123I-MIBG allows for visual and semi-quantitative assessment of sympathetic cardiac innervation using the hear to mediastinum ratio (HMR). Impaired cardiac MIBG clearance may occur in patients with congestive heart failure (CHF). The purpose of present study was to develop and validate a quantitative index for the assessment of cardiac MIBG uptake kinetics using SPECT/CT for diagnosis of CHF
3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.
This study's enrollment of 50 is below the median of 294 across 1,241 observational studies indexed under Heart Diseases.
Browse Heart Diseases studies →Rambam Health Care Campus is the lead sponsor of 456 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients refered for neuroendocrine diseases
Exclusion Criteria:
GE INFINIA HAWKEYE
The impact of the imaging modality on patient management
Time frame: 2 years
The impact on patient management
Time frame: 2 years
This study is completed, as verified in Aug 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rambam Health Care Campus